950772-98-2Relevant academic research and scientific papers
1- (1-CYCLOHEXYL-4-PIPERIDINYL) -1, 3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE M1 RECEPTOR AND THEIR USE IN MEDICINE
-
Page/Page column 51-52, (2008/12/04)
Compounds of formula (I) or a salt thereof are provided, wherein R4, R5, R6, Q, R1 and R2 are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments
COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
-
Page/Page column 50, (2008/12/04)
Compounds of Formula (I) or a salt thereof are provided: wherein R4, R5, R6, Q, R1 and R2 are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments
1- (1-CYCLOHEXYL-4-PIPERIDINYL) -1, 3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE M1 RECEPTOR AND THEIR USE IN MEDICINE
-
Page/Page column 55, (2008/12/04)
Compounds of Formula (I) or a salt thereof are provided: wherein R1, R2, R4, R5, R6, Q and Z are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicamen
SUBSTITUTED BENZIMIDAZOLONE COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
-
Page/Page column 47, (2008/12/04)
Compounds of formula (I) or a salt thereof are provided:(I) wherein R4, R5, R6, Q and n are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic d
COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
-
Page/Page column 48-49, (2008/12/04)
Compounds of Formula (I) or a salt thereof are provided: wherein R4, R5, R6, Q and R1 are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating ps
BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
-
Page/Page column 118-119, (2008/06/13)
Compounds of formula (I), salts and solvates are provided: formula (I), wherein Q, R and R6 are as defined in the claims. Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.
